Trade

with

Albany Molecular Research Inc
(NASDAQ: AMRI)
AdChoices
22.65
+0.44
+1.98%
After Hours :
22.65
+0.00
+0.01%

Open

22.80

Previous Close

22.21

Volume (Avg)

227.79k (306.25k)

Day's Range

22.36-22.97

52Wk Range

9.71-23.31

Market Cap.

735.63M

Dividend Rate ( Yield )

-

Beta

1.76

Shares Outstanding

32.48M

P/E Ratio (EPS)

44.05 (0.51)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 246.58M

    • Net Income

    • 12.68M

    • Market Cap.

    • 735.63M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 6.31

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.76

    • Forward P/E

    • -

    • Price/Sales

    • 2.73

    • Price/Book Value

    • 2.85

    • Price/Cash flow

    • 54.05

      • EBITDA

      • 36.83M

      • Return on Capital %

      • 4.06

      • Return on Equity %

      • 6.94

      • Return on Assets %

      • 4.06

      • Book Value/Share

      • 7.80

      • Shares Outstanding

      • 32.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 15.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 1.47

          • 63.43

          • Net Income

            5-Year Annual Average

          • -9.20

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 30.18

            • 82.75

            • Pre-Tax Margin

            • 7.26

            • 39.38

            • Net Profit Margin

            • 6.31

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 25.50

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -11.50

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -10.50

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.48

              • 0.76

              • Current Ratio

              • 5.20

              • 2.92

              • Quick Ratio

              • 3.90

              • 2.35

              • Interest Coverage

              • 3.83

              • 38.02

              • Leverage Ratio

              • 2.05

              • 2.21

              • Book Value/Share

              • 7.80

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 43.67

                • 243.90

                • P/E Ratio 5-Year High

                • 45.41

                • 634.30

                • P/E Ratio 5-Year Low

                • 4.05

                • 124.82

                • Price/Sales Ratio

                • 2.76

                • 9.29

                • Price/Book Value

                • 2.88

                • 8.39

                • Price/Cash Flow Ratio

                • 54.05

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 6.94

                        (-7.70)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • 4.06

                        (-6.20)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • 7.34

                        (-7.70)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • 12.56k

                      • 117.08k

                      • Inventory Turnover

                      • 4.48

                      • 1.48

                      • Asset Turnover

                      • 0.64

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      20.18M
                      Operating Margin
                      8.18
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      54.05
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      57.74%

                      Mutual Fund Ownership

                      30.18%

                      Float

                      73.96%

                      5% / Insider Ownership

                      20.48%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • DFA US Small Cap Value II Portfolio

                      •  

                        873,537

                      • 0.00

                      • 2.69

                      • Royce Opportunity Fund

                      •  

                        700,710

                      • -9.82

                      • 2.16

                      • iShares Core S&P Small-Cap (AU)

                      •  

                        474,148

                      • 0.24

                      • 1.49

                      • Legg Mason Royce US Small Cap Opp

                      •  

                        435,000

                      • 3.08

                      • 1.34

                      • iShares Nasdaq Biotechnology

                      •  

                        423,180

                      • -1.85

                      • 1.33

                      • Vanguard Total Stock Mkt Idx

                      •  

                        395,242

                      • 0.00

                      • 1.22

                      • iShares Russell 2000 (AU)

                      •  

                        364,857

                      • -0.89

                      • 1.14

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        345,122

                      • 1.08

                      • 1.06

                      • SEB Concept BioTech

                      •  

                        263,200

                      • 14.63

                      • 0.81

                      • Vanguard Extended Market Index Fund

                      •  

                        252,356

                      • 0.00

                      • 0.78

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Bessemer Trust Co Of Delaware, N.a.

                      •  

                        4,293,289

                      • -5.96%

                      • 13.27

                      • Dimensional Fund Advisors, Inc.

                      •  

                        2,716,245

                      • +3.31%

                      • 8.38

                      • Visium Asset Management LLC

                      •  

                        2,170,000

                      • -31.11%

                      • 6.69

                      • Wellington Management Company, LLP

                      •  

                        1,564,852

                      • -6.66%

                      • 4.83

                      • BlackRock Fund Advisors

                      •  

                        1,519,059

                      • +46.82%

                      • 4.69

                      • Evercore Wealth Management, LLC

                      •  

                        1,331,480

                      • 0.00%

                      • 4.11

                      • Royce & Associates, LLC

                      •  

                        1,315,610

                      • -2.16%

                      • 4.06

                      • Acadian Asset Management LLC

                      •  

                        1,259,249

                      • 0.00%

                      • 3.88

                      • Millennium Management LLC

                      •  

                        910,133

                      • -10.96%

                      • 2.81

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      Albany Molecular Research Inc is a Delaware corporation incorporated on June 20, 1991. It is a contract research and manufacturing organization providing customers integrated drug discovery, development and manufacturing services. Th...moree Company provides services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of Active Pharmaceutical Ingredients (API) and drug product for existing and experimental new drugs, as well as research, development and manufacturing for the agrochemical and other industries. With locations in the United States, Europe, and Asia, it maintains geographic proximity and flexible cost models. The Company has organized its activities into two distinct segments: Large Scale Manufacturing (LSM) and Discovery, Drug Developme...morent and Small-Scale Manufacturing (DDS). Its LSM activities include pilot- to commercial-scale production of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling, and high potency and controlled substance manufacturing. Its remaining activities, including drug lead discovery, in vitro biology and DMPK, lead optimization, drug development, and small-scale commercial manufacturing, represent its DDS business segment. Its Drug Discovery Services includes assay development and design, screening, natural product services, custom synthesis and library synthesis, medicinal chemistry, bioanalytical services, among others. Its customers include pharmaceutical companies and biotechnology companies, as well as government research entities and non-profit organizations, which are a growing segment of its customer base. It also sells to a more limited extent, to companies who are in the businesses of agriculture, fine chemicals, contract chemical manufacturing, medical devices, and flavoring and cosmetics. The Company competes with contract research companies, contract drug manufacturing companies, research and academic institutions and with the internal research departments of biotechnology companies. The manufacture, transportation and storage of its products are subject to certain international, Federal, state and local laws and regulations.lessless

                      Key People

                      William S. Marth

                      CEO/Director/President

                      Dr. Thomas E. D'Ambra,PhD

                      Chairman of the Board/Co-Founder/Director

                      Mr. Michael Nolan

                      CFO/Chief Accounting Officer/Treasurer/Senior Vice President

                      Mr. Brian D. Russell

                      Vice President, Divisional

                      Arthur J. Roth

                      Director

                      • Albany Molecular Research Inc

                      • 26 Corporate Circle

                      • Albany, NY 12203

                      • USA.Map

                      • Phone: +1 518 512-2000

                      • Fax: -

                      • amriglobal.com

                      Incorporated

                      1991

                      Employees

                      1,282

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: